In half of hypertensive diabetics, co-administration of a calcium channel blocker and an angiotensin-converting enzyme inhibitor achieved a target blood pressure of <130/80 mmHg: the azelnidipine and temocapril in hypertensive patients with type 2 d (Q46275681)
Jump to navigation
Jump to search
scientific article published in August 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | In half of hypertensive diabetics, co-administration of a calcium channel blocker and an angiotensin-converting enzyme inhibitor achieved a target blood pressure of <130/80 mmHg: the azelnidipine and temocapril in hypertensive patients with type 2 d |
scientific article published in August 2008 |
Statements
1 reference
In half of hypertensive diabetics, co-administration of a calcium channel blocker and an angiotensin-converting enzyme inhibitor achieved a target blood pressure of <130/80 mmHg: the azelnidipine and temocapril in hypertensive patients with type 2 d (English)
1 reference
Shigehiro Katayama
1 reference
Ryuzo Kawamori
1 reference
Yasuhiko Iwamoto
1 reference
Ikuo Saito
1 reference
Kizuku Kuramoto
1 reference
ATTEST Study Group
1 reference
1 August 2008
1 reference
1 reference
31
1 reference
8
1 reference
1499-1508
1 reference
Identifiers
1 reference